Individualization of the Immunosuppressive Therapy in Patients of Renal Transplantations through Pharmacodynamic and Pharmacogenetic Biomarkers

DSpace Repositorium (Manakin basiert)

Individualization of the Immunosuppressive Therapy in Patients of Renal Transplantations through Pharmacodynamic and Pharmacogenetic Biomarkers

Abdel-Kahaar Eldardir Ahmed, Emaad
Dateien:
Thumbnail
2.15 MB
PDF
Zitierfähiger Link (URI): http://hdl.handle.net/10900/74723
http://nbn-resolving.de/urn:nbn:de:bsz:21-dspace-747230
http://dx.doi.org/10.15496/publikation-16126
Dokumentart: Dissertation
Erscheinungsdatum: 2017
Sprache: Englisch
Fakultät: 4 Medizinische Fakultät
Fachbereich: Medizin
Gutachter: Wieland, Eberhard (Prof. Dr.)
Tag der mündl. Prüfung: 2017-02-10
DDC-Klassifikation: 610 - Medizin, Gesundheit
Schlagworte: Pharmakologie , Transplantation
Freie Schlagwörter:
Immunosuppressive drugs
organ transplantation
Lizenz: http://tobias-lib.uni-tuebingen.de/doku/lic_mit_pod.php?la=de http://tobias-lib.uni-tuebingen.de/doku/lic_mit_pod.php?la=en
Gedruckte Kopie bestellen: Print-on-Demand
Zur Langanzeige

Abstract:

The aim of this work was to look for specific biomarkers that could help to guide therapy with immunosuppressive drugs after organ transplantation. This work entailed the analytical validation of two pharmacodynamic biomarker assays. These include “NFAT-regulated gene expression assay” to monitor therapy with calcineurin inhibitors and “phosphoflow assay of S6RP” to monitor therapy with mTOR inhibitors. Additionally, a retrospective pharmacogenetic study to investigate the frequency and the impact of 6 SNPs in the genes of CYP450 and ABAB1 on tacrolimus pharmacokinetics early after transplantation in a cohort of 121 renal transplant recipients was also conducted.

Das Dokument erscheint in: